RBH launches new partnership with Alzheimer’s Research UK

RBH launch new partnership with Alzheimer’s Research UK on World Alzheimer’s Day

A new partnership between RBH and Alzheimer’s Research UK starts on World Alzheimer’s Day, on Friday.

Alzheimer’s Research UK has been chosen by RBH tenant and employee members as the new RBH members’ charity.

Every two years, RBH members choose a new charity to support. Over the summer, members were asked to nominate their favourite charities; tenants and employees on the RBH community funding panel whittled down these nominations to a shortlist of four: Alzheimer’s Research UK, HOPE, Hornets Sporting Foundation, and Rochdale Samaritans.

A vote was then taken at the RBH Annual Members Meeting, held at Middleton Arena on Tuesday 11 September, and RBH members chose Alzheimer’s Research UK.

Alzheimer's Research UK is the UK’s leading research charity aiming to make breakthroughs in dementia research possible. The charity’s pioneering work focuses on prevention, treatment and cure, and they aim to empower people across all generations through greater understanding of dementia.

Previous RBH members charities include Rochdale & District Mind, and Springhill Hospice. RBH raised over £13,000 for Rochdale & District Mind between 2016 and 2018.

Sue Kershaw, RBH membership manager, said: “With so many fantastic charities shortlisted, it was a really difficult decision for our members.

"We are delighted to be able to start our new adventure with Alzheimer’s Research UK, and we are looking forward to raising lots of money for such a fantastic cause - and hopefully having some fun along the way.”

Jess Sayer, regional fundraising manager at Alzheimer’s Research UK, said: “We are delighted that RBH has chosen to support Alzheimer's Research UK and we can’t wait to get our partnership started.

"Our cause is clearly one that resonated with members, which is no surprise as one in three of us know someone living with dementia today.

"With the support of RBH, we will be able to make breakthroughs possible and bring about the life-changing treatments we desperately need for this condition.”